ABOUT THIS EPISODE
What does it take to move a scientific idea from the bench to patients, especially in some of biotech’s most challenging therapeutic areas?
In this episode, Elaine Hamm, PhD, sits down with Gareth Willis, PhD, COO of Otologic Pharmaceutics and CEO of Exosla Therapeutics, for a candid conversation about translational science, biotech leadership, and the realities of drug development. Drawing from his experience across academia, Big Pharma, and startups, Gareth shares lessons from working in the biotech ecosystem, leading complex biologics programs, and developing therapies for hearing loss and tinnitus.
In this episode, you’ll learn:
Tune in to learn how biotech leaders are navigating the highs and lows of drug development while working to bring meaningful therapies to patients with unmet medical needs.
Links:
Connect with Gareth Willis, PhD, and learn about Otologic Pharmaceutics and Exosla Therapeutics.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Life Science Courses from Gareth:
Pharmaceutical Portfolio Strategies: Governance and Portfolio Management
Advanced Due Diligence in Pharmaceuticals
Pharmacology Essentials Training: Understanding Pharmacology in Drug Development
Mastering Development and Regulatory Strategies in Cell Therapy
Learn more about Elaine’s wine pub, The Study.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
In this episode, Elaine Hamm, PhD, sits down with Gareth Willis, PhD, COO of Otologic Pharmaceutics and CEO of Exosla Therapeutics, for a candid conversation about translational science, biotech leadership, and the realities of drug development. Drawing from his experience across academia, Big Pharma, and startups, Gareth shares lessons from working in the biotech ecosystem, leading complex biologics programs, and developing therapies for hearing loss and tinnitus.
In this episode, you’ll learn:
- Why translational science and patient impact became the driving force behind Gareth’s move from academia into biotech.
- How emerging technologies like AI are reshaping drug discovery and development timelines.
- What separates successful preclinical programs from the ones that fail, and why patient-centered thinking matters from day one.
Tune in to learn how biotech leaders are navigating the highs and lows of drug development while working to bring meaningful therapies to patients with unmet medical needs.
Links:
Connect with Gareth Willis, PhD, and learn about Otologic Pharmaceutics and Exosla Therapeutics.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Life Science Courses from Gareth:
Pharmaceutical Portfolio Strategies: Governance and Portfolio Management
Advanced Due Diligence in Pharmaceuticals
Pharmacology Essentials Training: Understanding Pharmacology in Drug Development
Mastering Development and Regulatory Strategies in Cell Therapy
Learn more about Elaine’s wine pub, The Study.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors.
OTHER EPISODES IN THIS PODCAST
Could family offices help biotech founders unlock new sources of capital in an increasingly challenging fundraising environment?
In this episode, host Elaine Hamm, PhD, sits down with Danielle Patterson, Executive Director of Family Office at ISS Market Intelligence, to explore the growing role of …
How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of …
How do you turn a room full of strangers into meaningful professional relationships?
In the second installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Zanewicz, JD, LLM, RTTP, to discuss what happens after you've done the preparation…
How can students start building a future in biotech before they even leave the lab?
In this episode, host Elaine Hamm, PhD, sits down with Haley Marcotte, Co-Managing Director of Nucleate New Orleans and a PhD student at Tulane University School of Medicine. Haley shares how discovering biotech as …
Have you ever left a conference with a stack of business cards… only to realize weeks later that you never followed up with the people you were most excited to meet?
In the final installment of their three-part networking series, Elaine Hamm, PhD, is joined once again by special guest host James Za…
Disclaimer: The podcast and artwork embedded on this page are from Elaine Hamm, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
